SHINE shares update on LEU-based method for Mo-99 production

01/21/2013 | Wisconsin State Journal (Madison)

SHINE Medical Technologies said the Los Alamos National Laboratory had succeeded in producing and separating molybdenum-99 from uranium sulfate solution. SHINE said the development shows the low-enriched uranium-based method can be used to produce the isotope on a commercial scale. The company is looking to meet at least 50% of the U.S. demand for the isotope by 2016.

View Full Article in:

Wisconsin State Journal (Madison)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Director, Payer Marketing
Avalere Health
Washington, DC
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Senior Officer, Drugs and Medical Devices
The Pew Charitable Trusts
Washington, DC